The working group runs a platform to evaluate the efficacy of new drugs and to select optimal treatment options for tuberculosis patients. In vitro test systems are available for preclinical testing, which are used to test the activity of substances against tuberculosis-causing mycobacteria. An aerosol inhalation mouse model is available [...]

New HIV infections occur mostly outside of Europe. That is why the DZIF has set up its own task force to coordinate clinical trials on location (mainly in Africa). This infrastructure gives DZIF member institutions access to large existing cohorts and biobanks that they can use for clinical trials of [...]